Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1797-1806

  Min, Hyun Jin ^a   Ko, Eun Ae ^a   Wu, Jie ^a   Kim, Eun Sung ^a   Kwon, Min Kyung ^a   Kwak, Man Sup ^a   Choi, Ji Eun ^b   Lee, Jong Eun ^a   Shin, Jeon Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University Boramae Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; HIGH MOBILITY GROUP B1 PROTEIN; HUNTINGTIN; INSULIN; LYSOZYME; POLYGLUTAMINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT HIGH MOBILITY GROUP B1 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CHAPERONE LIKE ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ENZYME INACTIVATION; GENETIC TRANSFECTION; HEAT SHOCK; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN AGGREGATION INHIBITION; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN REFOLDING;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CRICETINAE; CRICETULUS; HEK293 CELLS; HMGB1 PROTEIN; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; NEUROBLASTOMA; NIH 3T3 CELLS; PEPTIDES;

EID: 84873540749     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202472     Document Type: Article

References (58)

1. Goodwin, G. H., C. Sanders, and E. W. Johns. 1973. A new group of chromatinassociated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38: 14-19.
2. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
3. Einck, L., and M. Bustin. 1985. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp. Cell Res. 156: 295-310.
4. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
5. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
6. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
7. Ombrellino, M., H. Wang, M. S. Ajemian, A. Talhouk, L. A. Scher, S. G. Friedman, and K. J. Tracey. 1999. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 354: 1446-1447.
8. Sundén-Cullberg, J., A. Norrby-Teglund, A. Rouhiainen, H. Rauvala, G. Herman, K. J. Tracey, M. L. Lee, J. Andersson, L. Tokics, and C. J. Treutiger. 2005. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 33: 564-573.
9. Hatada, T., H. Wada, T. Nobori, K. Okabayashi, K. Maruyama, Y. Abe, S. Uemoto, S. Yamada, and I. Maruyama. 2005. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb. Haemost. 94: 975-979.
10. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
11. Tang, D., R. Kang, K. M. Livesey, C. W. Cheh, A. Farkas, P. Loughran, G. Hoppe, M. E. Bianchi, K. J. Tracey, H. J. Zeh, III, and M. T. Lotze. 2010. Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190: 881-892.
12. David, D. C., N. Ollikainen, J. C. Trinidad, M. P. Cary, A. L. Burlingame, and C. Kenyon. 2010. Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol. 8: e1000450.
13. Gidalevitz, T., A. Ben-Zvi, K. H. Ho, H. R. Brignull, and R. I. Morimoto. 2006. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311: 1471-1474.
14. Vendruscolo, M. 2012. Proteome folding and aggregation. Curr. Opin. Struct. Biol. 22: 138-143.
15. Bjørkøy, G., T. Lamark, A. Brech, H. Outzen, M. Perander, A. Overvatn, H. Stenmark, and T. Johansen. 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171: 603-614.
16. Filimonenko, M., S. Stuffers, C. Raiborg, A. Yamamoto, L. Malerød, E. M. Fisher, A. Isaacs, A. Brech, H. Stenmark, and A. Simonsen. 2007. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J. Cell Biol. 179: 485-500.
17. Moreau, K. L., and J. A. King. 2012. Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends Mol. Med. 18: 273-282.
18. Tartaglia, G. G., S. Pechmann, C. M. Dobson, and M. Vendruscolo. 2007. Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem. Sci. 32: 204-206.
19. Orr, H. T. 2012. Cell biology of spinocerebellar ataxia. J. Cell Biol. 197: 167-177.
20. Penney, J. B., Jr., J. P. Vonsattel, M. E. MacDonald, J. F. Gusella, and R. H. Myers. 1997. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann. Neurol. 41: 689-692.
21. Ross, C. A., and M. A. Poirier. 2004. Protein aggregation and neurodegenerative disease. Nat. Med. 10(Suppl): S10-S17.
22. Vachharajani, S. N., R. K. Chaudhary, S. Prasad, and I. Roy. 2012. Length of polyglutamine tract affects secondary and tertiary structures of huntingtin protein. Int. J. Biol. Macromol. 51: 920-925.
23. Bence, N. F., R. M. Sampat, and R. R. Kopito. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555.
24. McCampbell, A., J. P. Taylor, A. A. Taye, J. Robitschek, M. Li, J. Walcott, D. Merry, Y. Chai, H. Paulson, G. Sobue, and K. H. Fischbeck. 2000. CREBbinding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9: 2197-2202.
25. Hartl, F. U., A. Bracher, and M. Hayer-Hartl. 2011. Molecular chaperones in protein folding and proteostasis. Nature 475: 324-332.
26. Hageman, J., M. A. van Waarde, A. Zylicz, D. Walerych, and H. H. Kampinga. 2011. The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem. J. 435: 127-142.
27. Turturici, G., G. Sconzo, and F. Geraci. 2011. Hsp70 and its molecular role in nervous system diseases. Biochem. Res. Int. 2011: 618127.
28. Yamagishi, N., K. Goto, S. Nakagawa, Y. Saito, and T. Hatayama. 2010. Hsp105 reduces the protein aggregation and cytotoxicity by expanded- polyglutamine proteins through the induction of Hsp70. Exp. Cell Res. 316: 2424-2433.
29. Labbadia, J., S. S. Novoselov, J. S. Bett, A. Weiss, P. Paganetti, G. P. Bates, and M. E. Cheetham. 2012. Suppression of protein aggregation by chaperone modification of high molecular weight complexes. Brain 135: 1180-1196.
30. Sellamuthu, S., B. H. Shin, H. E. Han, S. M. Park, H. J. Oh, S. H. Rho, Y. J. Lee, and W. J. Park. 2011. An engineered viral protease exhibiting substrate specificity for a polyglutamine stretch prevents polyglutamine-induced neuronal cell death. PLoS ONE 6: e22554.
31. Youn, J. H., and J. S. Shin. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177: 7889-7897.
32. Youn, J. H., Y. J. Oh, E. S. Kim, J. E. Choi, and J. S. Shin. 2008. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-α production in human monocytes. J. Immunol. 180: 5067-5074.
33. Horwitz, J., M. Bova, Q. L. Huang, L. Ding, O. Yaron, and S. Lowman. 1998. Mutation of alpha B-crystallin: effects on chaperone-like activity. Int. J. Biol. Macromol. 22: 263-269.
34. Nollen, E. A., A. E. Kabakov, J. F. Brunsting, B. Kanon, J. Höhfeld, and H. H. Kampinga. 2001. Modulation of in vivo HSP70 chaperone activity by Hip and Bag-1. J. Biol. Chem. 276: 4677-4682.
35. Sbroggiò, M., R. Ferretti, E. Percivalle, M. Gutkowska, A. Zylicz, W. Michowski, J. Kuznicki, F. Accornero, B. Pacchioni, G. Lanfranchi, et al. 2008. The mammalian CHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1. FEBS Lett. 582: 1788-1794.
36. Hands, S., M. U. Sajjad, M. J. Newton, and A. Wyttenbach. 2011. In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J. Biol. Chem. 286: 44512-44520.
37. Ivanov, S., A. M. Dragoi, X. Wang, C. Dallacosta, J. Louten, G. Musco, G. Sitia, G. S. Yap, Y. Wan, C. A. Biron, et al. 2007. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110: 1970-1981.
38. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560.
39. Novoselova, T. V., B. A. Margulis, S. S. Novoselov, A. M. Sapozhnikov, J. van der Spuy, M. E. Cheetham, and I. V. Guzhova. 2005. Treatment with extracellular HSP70/HSC70 protein can reduce polyglutamine toxicity and aggregation. J. Neurochem. 94: 597-606.
40. Bustin, M., and N. K. Neihart. 1979. Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells. Cell 16: 181-189.
41. Sims, G. P., D. C. Rowe, S. T. Rietdijk, R. Herbst, and A. J. Coyle. 2010. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28: 367-388.
42. Zhang, Y., Y. Cheng, X. Ren, L. Zhang, K. L. Yap, H. Wu, R. Patel, D. Liu, Z. H. Qin, I. M. Shih, and J. M. Yang. 2012. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response. Oncogene 31: 1055-1064.
43. Livesey, K. M., R. Kang, P. Vernon, W. Buchser, P. Loughran, S. C. Watkins, L. Zhang, J. J. Manfredi, H. J. Zeh, III, L. Li, et al. 2012. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res. 72: 1996-2005.
44. Kang, R., K. M. Livesey, H. J. Zeh, III, M. T. Lotze, and D. Tang. 2011. Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 7: 1256-1258.
45. Yanai, H., T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
46. Qi, M. L., K. Tagawa, Y. Enokido, N. Yoshimura, Y.Wada, K.Watase, S. Ishiura, I. Kanazawa, J. Botas, M. Saitoe, et al. 2007. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat. Cell Biol. 9: 402-414.
47. Jana, N. R., M. Tanaka, G. Wang, and N. Nukina. 2000. Polyglutamine lengthdependent interaction of Hsp40 and Hsp70 family chaperones with truncated Nterminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9: 2009-2018.
48. Kim, S., E. A. Nollen, K. Kitagawa, V. P. Bindokas, and R. I. Morimoto. 2002. Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4: 826-831.
49. Rujano, M. A., H. H. Kampinga, and F. A. Salomons. 2007. Modulation of polyglutamine inclusion formation by the Hsp70 chaperone machine. Exp. Cell Res. 313: 3568-3578.
50. Bertoni, A., P. Giuliano, M. Galgani, D. Rotoli, L. Ulianich, A. Adornetto, M. R. Santillo, A. Porcellini, and V. E. Avvedimento. 2011. Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins. J. Biol. Chem. 286: 4727-4741.
51. Wyttenbach, A., O. Sauvageot, J. Carmichael, C. Diaz-Latoud, A. P. Arrigo, and D. C. Rubinsztein. 2002. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet. 11: 1137-1151.
52. Tang, D., R. Kang, H. J. Zeh, III, and M. T. Lotze. 2011. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 14: 1315-1335.
53. Oh, Y. J., J. H. Youn, Y. Ji, S. E. Lee, K. J. Lim, J. E. Choi, and J. S. Shin. 2009. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J. Immunol. 182: 5800-5809.
54. Ribeiro, F. M., M. Paquet, L. T. Ferreira, T. Cregan, P. Swan, S. P. Cregan, and S. S. Ferguson. 2010. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease. J. Neurosci. 30: 316-324.
55. Tidwell, J. L., L. J. Houenou, and M. Tytell. 2004. Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration. Cell Stress Chaperones 9: 88-98.
56. Guzhova, I. V., A. C. Arnholdt, Z. A. Darieva, A. V. Kinev, E. B. Lasunskaia, K. Nilsson, V. M. Bozhkov, A. P. Voronin, and B. A. Margulis. 1998. Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones 3: 67-77.
57. Guzhova, I., K. Kislyakova, O. Moskaliova, I. Fridlanskaya, M. Tytell, M. Cheetham, and B. Margulis. 2001. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res. 914: 66-73.
58. Kalmar, B., and L. Greensmith. 2009. Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects. Cell. Mol. Biol. Lett. 14: 319-335.